Unique recurrence patterns of cervical intraepithelial neoplasia after excision of the squamocolumnar junction

International Journal of Cancer

Volumn 136, Issue 5, 2015, Pages 1043-1052

  Herfs, Michael ^a   Somja, Joan ^a   Howitt, Brooke E ^b   Suarez Carmona, Meggy ^a   Kustermans, Gaelle ^a   Hubert, Pascale ^a   Doyen, Jean ^a   Goffin, Frederic ^a   Kridelka, Frederic ^a   Crum, Christopher P ^b   Delvenne, Philippe ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cervical intraepithelial neoplasia; Excision; Follow up; HPV

Indexed keywords

AGR2 PROTEIN; CYTOKERATIN 7; GDA PROTEIN; MARKER; MATRILYSIN; PROTEIN P16; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GRADING; CONTROLLED STUDY; ELECTROSURGERY; FEMALE; FOLLOW UP; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN TISSUE; IMMUNOPHENOTYPING; LOOP ELECTROSURGICAL EXCISION PROCEDURE; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; PAPILLOMAVIRUS INFECTION; SQUAMOCOLUMNAR JUNCTION; TUMOR RECURRENCE; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX EPITHELIUM; WART VIRUS; CANCER STAGING; CERVICAL INTRAEPITHELIAL NEOPLASIA; ENZYME IMMUNOASSAY; HYSTERECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; NEOPLASMS, SQUAMOUS CELL; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTIONS; PATHOLOGY; PROGNOSIS; UTERINE CERVICAL NEOPLASMS; VIROLOGY; YOUNG ADULT;

ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; ELECTROSURGERY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYSTERECTOMY; IMMUNOENZYME TECHNIQUES; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL; NEOPLASMS, SQUAMOUS CELL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84925230007     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28978     Document Type: Article

References (27)

1. Crum CP, Ikenberg H, Richart RM, et al. Human papillomavirus type 16 and early cervical neoplasia. N Engl J Med 1984;310:880-3.
2. Durst M, Gissmann L, Ikenberg H, et al. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA 1983;80:3812-5.
3. Lehtinen M, Paavonen J, Wheeler CM, et al. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol 2012;13:89-99.
4. Paavonen J, Naud P, Salmeron J, et al. Efficacy of human papillomavirus (HPV) 216/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 2009;374:301-14.
5. Milojkovic M. Residual and recurrent lesions after conization for cervical intraepithelial neoplasia grade 3. Int J Gynaecol Obstet 2002;76:49-53.
6. Skjeldestad FE, Hagen B, Lie AK, et al. Residual and recurrent disease after laser conization for cervical intraepithelial neoplasia. Obstet Gynecol 1997;90:428-33.
7. Herfs M, Yamamoto Y, Laury A, et al. A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer. Proc Natl Acad Sci USA 2012;109:10516-21.
8. Herfs M, Vargas SO, Yamamoto Y, et al. A novel blueprint for 'top down' differentiation defines the cervical squamocolumnar junction during development, reproductive life, and neoplasia. J Pathol 2013;229:460-8.
9. Wang X, Ouyang H, Yamamoto Y, et al. Residual embryonic cells as precursors of a Barrett's-like metaplasia. Cell 2011;145:1023-35.
10. Herfs M, Parra-Herran C, Howitt BE, et al. Cervical squamocolumnar junction-specific markers define distinct, clinically relevant subsets of lowgrade squamous intraepithelial lesions. Am J Surg Pathol 2013;37:1311-8.
11. Mo LZ, Monnier-Benoit S, Kantelip B, et al. Comparison of AMPLICOR and Hybrid Capture II assays for high risk HPV detection in normal and abnormal liquid-based cytology: use of INNO-LiPA Genotyping assay to screen the discordant results. J Clin Virol 2008;41:104-10.
12. Herfs M, Hubert P, Poirrier AL, et al. Proinflammatory cytokines induce bronchial hyperplasia and squamous metaplasia in smokers: implications for chronic obstructive pulmonary disease therapy. Am J Respir Cell Mol Biol 2012;47:67-9.
13. Wright TC Jr, Massad LS, Dunton CJ, et al. 2006 Consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. Am J Obstet Gynecol 2007;197:340-5.
14. Wright TC Jr, Massad LS, Dunton CJ, et al. 2006 Consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol 2007;197:346-55.
15. Gök M, Coupé VM, Berkhof J, et al. HPV16 and increased risk of recurrence after treatment for CIN. Gynecol Oncol 2007;104:273-5.
16. Van Der Marel J, Van Baars R, Alonso I, et al. Oncogenic human papillomavirus-infected immature metaplastic cells and cervical neoplasia. Am J Surg Pathol 2014;38:470-9.
17. Prato B, Ghelardi A, Gadducci A, et al. Correlation of recurrence rates and times with posttreatment human papillomavirus status in patients treated with loop electrosurgical excision procedure conization for cervical squamous intraepithelial lesions. Int J Gynecol Cancer 2008;18:90-4.
18. Bais AG, Eijkemans MJ, Rebolj M, et al. Posttreatment CIN: randomized clinical trial using hrHPV testing for prediction of residual/recurrent disease. Int J Cancer 2009;124:889-95.
19. Kocken M, Helmerhorst TJ, Berkhof J, et al. Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: a long-term multi-cohort study. Lancet Oncol 2011;12:441-50.
20. Strander B, Hällgren J, Spáren P. Effect of ageing on cervical or vaginal cancer in Swedish women previously treated for cervical intraepithelial neoplasia grade 3: population based cohort study of long term incidence and mortality. Br Med J 2014;348:f7361
21. Petry KU, Scheffel D, Bode U, et al. Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions. Int J Cancer 1994;57:836-40.
22. Lima MI, Tafuri A, Araújo AC, et al. Cervical Intraepithelial neoplasia recurrence after conization in HIV-positive and HIV-negative women. Int J Gynaecol Obstet 2009;104:100-4.
23. Lodi CT, Michelin MA, Lima MI, et al. Factors associated with recurrence of cervical intraepithelial neoplasia after conization in HIV-infected and noninfected women. Arch Gynecol Obstet 2011;284:191-7.
24. McAllum B, Sykes PH, Sadler L, et al. Is the treatment of CIN 2 always necessary in women under 25 years old? Am J Obstet Gynecol 2011;205:478-7.
25. Moscicki AB, Ma Y, Wibbelsman C, et al. Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women. Obstet Gynecol 2010;116:1373-80.
26. Taylor S, Wang C, Wright TC, et al. Reduced acquisition and reactivation of human papillomavirus infections among older women treated with cryotherapy: results from a randomized trial in South Africa. Biomed Chromatogr Med 2010;8:40.
27. Younge PA. Cancer of the uterine cervix; a preventable disease. Obstet Gynecol 1957;10:469-81.